[3P-0899（2PT26-15）] Investigation of novel anti-cancer drug using by alpha-Particle Emitting Radionuclides

〇Kazuko Kaneda¹, Zi Jian Zhang^1,2, Takumi Ikeda², Akimitsu Kanda², Souichiro Ichimura², Yoshiyuki Manabe^1,3, Atsushi Shimoyama^1,3, Kazuya Kabayama^1,3, Koujiro Nagata⁷, Tadashi Watabe^1,4, Atsushi Toyoshima^1,5, Yoshikatsu Kanai⁶, Takashi Yoshimura^1,7, Mitsuhiro Fukuda^1,8, Koichi Fukase^1,3, Atsushi Shinohara^1,2 (1.MS-CORE, PRC, Grad. Sch. of Sci., Osaka Univ., 2.Radiochem., Dept., of Chem., Grad. Sch. of Sci., Osaka Univ., 3.Natur. Prod. Chem., Dept., of Chem., Grad. Sch. of Sci., Osaka Univ., 4.Nucl. Med., Dept., Grad. Sch. of Med., Osaka Univ., 5.Heavy Element Nucl., ASRC, JAEA, 6.Bio-System Pharm., Dept., Grad. Sch. of Med., Osaka Univ., 7.RI research center, Osaka Univ., 8.Accelerator, RNCP, Osaka Univ.)

RI、cancer、Astatine-211、Alpha-Particle、molecular targeting